American Society for Transplantation and Cellular Therapy Series, #6 : Management of Invasive Candidiasis in Hematopoietic Cell Transplantation Recipients
Copyright © 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved..
The Practice Guidelines Committee of the American Society of Transplantation and Cellular Therapy (ASTCT) partnered with its Transplant Infectious Disease Special Interest Group (TID-SIG) to update its 2009 compendium-style infectious disease guidelines for hematopoietic cell transplantation (HCT). A completely new approach was taken with the goal of better serving clinical providers by publishing each standalone topic in the infectious disease series as a concise format of frequently asked questions (FAQ), tables, and figures. Adult and pediatric infectious disease and HCT content experts developed and then answered FAQs and finalized topics with harmonized recommendations made by assigning an A through E strength of recommendation paired with a level of supporting evidence graded I through III. This sixth guideline in the series focuses on invasive candidiasis (IC) with FAQs to address epidemiology, clinical diagnosis, prophylaxis, and treatment of IC, plus special considerations for pediatric, cord blood, haploidentical, and T cell-depleted HCT recipients and chimeric antigen receptor T cell recipients, as well as future research directions.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
|---|---|
| Enthalten in: |
Transplantation and cellular therapy - 29(2023), 4 vom: 28. Apr., Seite 222-227 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Neofytos, Dionysios [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Candida |
|---|
| Anmerkungen: |
Date Completed 28.03.2023 Date Revised 16.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jtct.2023.01.011 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM351605630 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM351605630 | ||
| 003 | DE-627 | ||
| 005 | 20231226051801.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jtct.2023.01.011 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1171.xml |
| 035 | |a (DE-627)NLM351605630 | ||
| 035 | |a (NLM)36649748 | ||
| 035 | |a (PII)S2666-6367(23)00035-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Neofytos, Dionysios |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a American Society for Transplantation and Cellular Therapy Series, #6 |b Management of Invasive Candidiasis in Hematopoietic Cell Transplantation Recipients |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.03.2023 | ||
| 500 | |a Date Revised 16.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a The Practice Guidelines Committee of the American Society of Transplantation and Cellular Therapy (ASTCT) partnered with its Transplant Infectious Disease Special Interest Group (TID-SIG) to update its 2009 compendium-style infectious disease guidelines for hematopoietic cell transplantation (HCT). A completely new approach was taken with the goal of better serving clinical providers by publishing each standalone topic in the infectious disease series as a concise format of frequently asked questions (FAQ), tables, and figures. Adult and pediatric infectious disease and HCT content experts developed and then answered FAQs and finalized topics with harmonized recommendations made by assigning an A through E strength of recommendation paired with a level of supporting evidence graded I through III. This sixth guideline in the series focuses on invasive candidiasis (IC) with FAQs to address epidemiology, clinical diagnosis, prophylaxis, and treatment of IC, plus special considerations for pediatric, cord blood, haploidentical, and T cell-depleted HCT recipients and chimeric antigen receptor T cell recipients, as well as future research directions | ||
| 650 | 4 | |a Practice Guideline | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Candida | |
| 650 | 4 | |a Diagnosis | |
| 650 | 4 | |a Epidemiology | |
| 650 | 4 | |a Guidelines | |
| 650 | 4 | |a Hematopoietic cell transplantation | |
| 650 | 4 | |a Invasive candidiasis | |
| 650 | 4 | |a Prophylaxis | |
| 650 | 4 | |a Treatment | |
| 700 | 1 | |a Steinbach, William J |e verfasserin |4 aut | |
| 700 | 1 | |a Hanson, Kimberly |e verfasserin |4 aut | |
| 700 | 1 | |a Carpenter, Paul A |e verfasserin |4 aut | |
| 700 | 1 | |a Papanicolaou, Genovefa A |e verfasserin |4 aut | |
| 700 | 1 | |a Slavin, Monica A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Transplantation and cellular therapy |d 2021 |g 29(2023), 4 vom: 28. Apr., Seite 222-227 |w (DE-627)NLM307596486 |x 2666-6367 |7 nnns |
| 773 | 1 | 8 | |g volume:29 |g year:2023 |g number:4 |g day:28 |g month:04 |g pages:222-227 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jtct.2023.01.011 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 29 |j 2023 |e 4 |b 28 |c 04 |h 222-227 | ||